Leuko Labs Inc.
An MIT spinout measuring white blood cells, using light, to improve cancer patient outcomes
Members
Carlos Castro-Gonzalez
Co-Founder of Leuko Labs Inc.
Healthcare innovator for more than 15 years. Carlos holds an MSc in Electrical Engineering from the Royal Institute of Technology (Sweden) and a PhD in biomedical engineering from the Technical University of Madrid (Spain). He is an expert in medical image analysis and has previously led multidisciplinary teams developing solutions for cardiac diagnosis and meningitis detection. After his PhD, Carlos was selected for the prestigious M+Vision fellowship program at MIT to explore commercialization venues for novel technologies and was awarded top innovator under 35 in 2015 by MIT Technology Review. After MIT, Carlos co-founded Leuko, a medical device startup focused on improving quality of life and outcomes for cancer patients, through the first noninvasive white blood cell monitoring solution. As part of Leuko, Carlos has had ample experience securing dilutive and non-dilutive funding, conducting customer discovery, developing new IPs, and establishing clinical and technical collaborations to bring a new product to market.
Ask Me About:
-
- Spinning out academic research into a commercial venture
- Dilutive and non-dilutive fundraising
- Negotiating licensing agreements with the Technology Licensing Office
Ganimete Lamaj
Human Factors Engineer at Leuko Labs Inc.
I graduated from Boston University’s College of Engineering in 2019 with a degree in Biomedical Engineering and a concentration in Technology Innovation, and have been working for Leuko since. My current role is Human Factors Engineer.
Ask Me About:
- My favorite musician/band this month!
Ian Butterworth
Ask Me About:
- How to find unmet medical needs
- How to develop medical devices
- The Julia programming language
Ryan Benasutti